Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Baricitinib”

143 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 143 results

Post-approval studies (Phase 4)Active Not RecruitingNCT05300932
What this trial is testing

A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Tongji Hospital 60
Early research (Phase 1)Study completedNCT02340104
What this trial is testing

Measure Baricitinib (LY3009104) Absorption in Healthy Participants

Who this might be right for
Healthy Volunteers
Eli Lilly and Company 8
Testing effectiveness (Phase 2)UnknownNCT04346147
What this trial is testing

Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19

Who this might be right for
COVID-19 Pneumonia
Hospital Universitario de Fuenlabrada 168
Testing effectiveness (Phase 2)Study completedNCT01683409
What this trial is testing

Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Eli Lilly and Company 130
Testing effectiveness (Phase 2)Study completedNCT03026504
What this trial is testing

Baricitinib in Relapsing Giant Cell Arteritis

Who this might be right for
Arteritis, Giant Cell
Matthew J Koster 15
Testing effectiveness (Phase 2)Study completedNCT04916756
What this trial is testing

A Prospective Pilot Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome Patients

Who this might be right for
Sjogren's Syndrome
Peking Union Medical College Hospital 11
Large-scale testing (Phase 3)WithdrawnNCT04970719
What this trial is testing

Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus

Who this might be right for
COVID-19 Pneumonia
Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders
Large-scale testing (Phase 3)Looking for participantsNCT03773965
What this trial is testing

Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Eli Lilly and Company 190
Testing effectiveness (Phase 2)Study completedNCT04208464
What this trial is testing

JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM

Who this might be right for
Idiopathic Inflammatory Myopathies
University of Manchester 15
Large-scale testing (Phase 3)UnknownNCT04693026
What this trial is testing

Efficacy of Ramdicivir and Baricitinib for the Treatment of Severe COVID 19 Patients

Who this might be right for
Covid19Covid-19 ARDS
M Abdur Rahim Medical College and Hospital 150
Large-scale testing (Phase 3)Looking for participantsNCT06936215
What this trial is testing

Safety and Efficacy of Baricitinib on Skin Tightening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 24
Large-scale testing (Phase 3)Study completedNCT03334435
What this trial is testing

Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 1,645
Testing effectiveness (Phase 2)UnknownNCT04399798
What this trial is testing

Baricitinib for coRona Virus pnEumonia (COVID-19): a THerapeutic Trial

Who this might be right for
Corona Virus Infection
Fondazione IRCCS Policlinico San Matteo di Pavia 13
Large-scale testing (Phase 3)Looking for participantsNCT07222137
What this trial is testing

Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

Who this might be right for
Diabetes Mellitus, Type 1
Eli Lilly and Company 150
Post-approval studies (Phase 4)Study completedNCT04086745
What this trial is testing

Baricitinib in Participants With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 1,317
Testing effectiveness (Phase 2)Active Not RecruitingNCT06158113
What this trial is testing

Efficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept Study

Who this might be right for
Lichen Planus, OralLichen Planus, MucosalOral Lichen Planus
University of North Carolina, Chapel Hill 10
Testing effectiveness (Phase 2)UnknownNCT03755466
What this trial is testing

Examination of Efficacy and Safety of Baricitinib in RA Patients

Who this might be right for
Rheumatoid Arthritis
Shinshu University 90
Early research (Phase 1)Study completedNCT01960140
What this trial is testing

Baricitinib and Simvastatin in Healthy Participants

Who this might be right for
Healthy Volunteers
Eli Lilly and Company 40
Testing effectiveness (Phase 2)Looking for participantsNCT06065046
What this trial is testing

Baricitinib for Moderate and Severe Traumatic Intracerebral Hemorrhage/Contusions

Who this might be right for
Traumatic Brain Injury
Tang-Du Hospital 100
Large-scale testing (Phase 3)UnknownNCT03701789
What this trial is testing

Effect of Baricitinib Treatment on Peripheral Bone in RA

Who this might be right for
Rheumatoid ArthritisBone DensityFinger Joints
University of Erlangen-Nürnberg Medical School 15
Load More Results